Neurological Disorders Applications
-
N-Des[2-(2-hydroxyethoxy)ethyl] Quetiapine Dihydrochloride
A metabolite of Quetiapine. Quetiapine is an atypical antipsychotic used for the treatment of schizophrenia, bipolar disorder. https://www.bocsci.com/n-des-2-2-hydroxyethoxy-ethyl-quetiapine-dihydrochloride-cas-111974-74-4-item-54624.html ...
By Alfa Chemistry based in NY, NEW YORK (USA).
-
Temperature and fluid management medical device solutions for cardiac arrest sector
Cardiac Arrest: After successful resuscitation, patients who survive a cardiac arrest often remain severely ill and require intensive care. Controlling body temperature is a potential treatment that may prevent brain ...
By seiratherm GmbH based in Herzogenaurach, GERMANY.
-
22q11.2 Deletion Syndrome (22q)
22q is a disorder caused by a small missing piece of the 22nd chromosome. The deletion occurs near the middle of the chromosome at a location designated q11.2. It is considered a mid-line condition, with physical symptoms including characteristic palate abnormalities, heart defects, immune dysfunction, and esophageal / GI issues, as well as debilitating neuropsychiatric and behavioral ...
By Zynerba Pharmaceuticals, Inc. based in Devon, PENNSYLVANIA (USA).
-
Medical solutions for mild cognitive impairment
Mild Cognitive Impairment (MCI) is a clinical condition that affects one or more cognitive domains (memory, language, concentration). Nearly 900 thousand Italians are affected by it and it is prevalent from the age of 60. It is the first indicator of a disease that can become increasingly disabling and compound over time, increasing the risk of dementia. It is the transitional phase between normal aging and dementia, during which it is possible to intervene and delay the onset of the ...
By Neopharmed Gentili S.p.A. based in Milano, ITALY.
-
Software Solution for Healthcare Provider
Automated MRI analyses that may help inform earlier, more accurate viewsof CNS disease, such as Alzheimer’s, Parkinson’s and multiple sclerosis. For healthcare providers on the frontlines of diagnosing and treating central nervous system disease, and for your patients, Qynapse brings groundbreaking peace of mind by providing results you can trust through its flagship solution, QyScore. ...
By Qynapse based in Paris, FRANCE.
-
The Chrysalis Solution to Mitigate Radiation Therapy-Induced Tissue Damage
Prescriptive Use To Mitigate Radiotherapy Damage To Normal Tissue and Allow More Effective Cancer Therapy. Almost 70% of all patients with cancer receive radiotherapy alone or in combination with surgery or chemotherapy. The amount of radiation that can be used to control tumor growth, however, is limited by normal tissue damage. Development of drugs to selectively reduce radiotherapy-induced normal tissue damage may improve post-therapy quality of life and allow more aggressive radiotherapy protocols to better ...
By Chrysalis BioTherapeutics, Inc. based in Galveston, TEXAS (USA).
-
Flagship Coil for Obsessive-Compulsive Disorder (OCD) Treatment
Deep Transcranial Magnetic Stimulation, or Deep TMS, has been shown to safely and effectively alleviate the symptoms of obsessive-compulsive disorder (OCD), particularly those patients who have not achieved sufficient improvement from traditional OCD treatment ...
By BrainsWay Ltd. based in Burlington, MASSACHUSETTS (USA).
-
Evolving Depression Care for Professionals
Addressing the many sides of depression, the Flow treatment consists of a brain stimulation headset that targets the physical root-cause of depression and a behavioural therapy app to address the psychological and environmental ...
By Flow Neuroscience AB based in Malmö, SWEDEN.
-
Highly customized aptamer discovery solutions for aptamers in neurological disease sector
More than 5 million people in the United States and an estimated 50 million people worldwide are living with Alzheimer’s disease. More than 10 million people worldwide are living with Parkinson’s. Brain tumors and tumors of the central nervous system are the most common form of cancer in children under 19 and the leading cause of cancer-related deaths in children under 14 in the U.S. While antibody drugs have made great strides in cancer therapies, crossing the blood-brain barrier (BBB) and ...
By Base Pair Biotechnologies, Inc. based in Pearland, TEXAS (USA).
-
Flagship Coil for Major Depressive Disorder (MDD) Treatment
A revolutionary depression treatment that has changed the field of mental healthcare, Deep TMS has been FDA-cleared to safely and effectively treat Major Depressive Disorder through BrainsWay’s patented H-coil ...
By BrainsWay Ltd. based in Burlington, MASSACHUSETTS (USA).
-
Targeted genetic sequencing solutions for neurology sector
Over 50 million people globally are impacted by dementia. 25% of those over age 55 have a family history of dementia.* Tesis Labs Parkinson-Alzheimer-Dementia Panel examines 35 genes associated with an increased risk of developing neurodegenerative conditions: Parkinson’s disease, Alzheimer’s disease, Genetic disorders that cause ...
By Tesis Biosciences based in Scottsdale, ARIZONA (USA).
-
Monitoring and Assessment Device for Neurologist
Pheezee is suitable for patients with neurological disorders. It can detect isometric contractions of muscles as well as minute muscular activity known as flickers. The muscular firings recorded in Pheezee reports help in quantifying the incremental recovery of the muscles, thereby giving hope and motivating the patient to recover ...
By Startoon Labs based in Secunderabad, INDIA.
-
Industrial Blades, Machine Knives and Special Cutting Tools for Neurology
Vector Medical, as a reliable partner for medical device OEMs, designs and manufactures high quality medical cutting instruments and incision components used in Neurotechnology well as Neurosurgery (Neurological Surgery). Vector Medical manufactures extremely precise incision parts and cutting instruments for these procedures to improve surgery and patient outcome. These procedures that require the incision parts to be made from high quality materials such as Nickel titanium (also known as nitinol) can be ...
By Vector Medical based in Irvine, CALIFORNIA (USA).
-
Solutions for Neuroscience
Our driving philosophy at Otsuka is to serve those with unmet medical needs, and that couldn’t be more true than in our dedication to the central nervous system (CNS) space. In our 30 years of experience working in this therapeutic area, we continue to innovate and defy limitation by taking risks to overcome the complexities of treating mental health. We respect the value within every mind and are committed to making a difference in the lives of patients living with schizophrenia, major depressive disorder, ...
By Otsuka America Pharmaceutical, Inc based in Princeton, NEW JERSEY (USA).
-
Flagship Coil for Smoking Addiction Treatment
BrainsWay Deep Transcranial Magnetic Stimulation (Deep TMS) is a safe and effective aid for short-term smoking cessation in adults, representing the first FDA clearance in the addiction space for any TMS ...
By BrainsWay Ltd. based in Burlington, MASSACHUSETTS (USA).
-
Flagship Coil for Alzheimer’s Disease Treatment
Alzheimer’s disease is a major cause of severe cognitive decline in the aged. The primary cognitive deficiencies are revealed in working memory, language, executive functions, attention, and long-term ...
By BrainsWay Ltd. based in Burlington, MASSACHUSETTS (USA).
-
Flagship Coil for Autism Disorder Treatment Technology
Autism is a complex developmental disability that typically appears during the first three years of life and is the result of a neurological disorder that affects the normal functioning of the brain. Autism is characterized by three kinds of symptoms: deficiency in social interaction, difficulties in verbal and non-verbal communication, and severe disabilities in interest areas and activities. In addition, autistic people may develop extreme reactions to noise, touch, or other sensory stimuli. These symptoms are ...
By BrainsWay Ltd. based in Burlington, MASSACHUSETTS (USA).
-
Potent, Long-Lasting, Infusion Therapy for Patients
Heart failure is a progressive syndrome that begins with a chronic condition that often leads to Acute Decompensated Heart Failure, an unstable condition requiring immediate medical ...
By ViCardia Therapeutics, Inc. based in San Francisco, CALIFORNIA (USA).
-
Brain Interfaces Device for Reconnecting Thought to Action
The Link is a starting point for a new kind of brain interface. As our technology develops, we will be able to increase the channels of communication with the brain, accessing more brain areas and new kinds of neural information. This technology has the potential to treat a wide range of neurological disorders, to restore sensory and movement function, and eventually to expand how we interact with each other, with the world, and with ...
By Neuralink based in San Francisco, CALIFORNIA (USA).
-
Rehabilitation Robotics to Optimize Patient Outcomes and Simplify Workflows
Assistive rehabilitation technology for your hospital, clinic or therapy centre: Axinesis’s cost-effective and clinically proven neurorehabilitation devices help optimize patient outcomes while simplifying your workflows and maximizing therapy time. At Axinesis, we understand you want every patient to achieve the best possible functional outcomes, including return to activities of daily living and social participation. We also understand the challenges and limitations of providing manual therapy. Our ...
By Axinesis based in Wavre, BELGIUM.
Need help finding the right suppliers? Try XPRT Sourcing. Let the XPRTs do the work for you